InvestorsHub Logo
Followers 2432
Posts 91329
Boards Moderated 5
Alias Born 09/12/2003

Re: Mrragu post# 27030

Sunday, 04/19/2020 1:50:50 AM

Sunday, April 19, 2020 1:50:50 AM

Post# of 35961
Published: 17 June 2019! Look like they continues Study of Mipsagargin (G-202)
Received: 22 May 2019 / Revised: 11 June 2019 / Accepted: 13 June 2019 / Published: 17 June 2019

A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma

https://www.mdpi.com/2072-6694/11/6/833/htm

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News